The estimated Net Worth of Mark Jeffrey Manoff is at least $866 Mille dollars as of 11 May 2022. Mr. Manoff owns over 7,718 units of Covetrus stock worth over $558,229 and over the last 5 years he sold CVET stock worth over $0. In addition, he makes $307,500 as Independent Director at Covetrus.
Mark has made over 2 trades of the Covetrus stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 7,718 units of CVET stock worth $162,001 on 11 May 2022.
The largest trade he's ever made was exercising 24,089 units of Covetrus stock on 13 May 2021 worth over $505,628. On average, Mark trades about 6,361 units every 73 days since 2020. As of 11 May 2022 he still owns at least 26,595 units of Covetrus stock.
You can see the complete history of Mr. Manoff stock trades at the bottom of the page.
Mark J. Manoff is Independent Director of the Company. Mr. Manoff was a co-founder and Chief Executive Officer of Verrian, Inc. through 2019. He was a partner of EY LLP (“EY”, formerly known as Ernst & Young LLP) from 1990 until his retirement as Americas Vice Chair in 2017. During his time with EY, Mr. Manoff held various positions including New York Office Managing Partner and Northeast Region Managing Partner. He also founded and led the EY Center for Board Matters. Mr. Manoff is a member of the Board of Directors of The First Tee of Metropolitan New York, a youth development organization. In addition, Mr. Manoff was a member of the Board of Directors for Roundabout Theatre in New York City for approximately 10 years (through May 2018) and was chair of its audit committee during that period. Mr. Manoff serves on the Advisory Board (previously serving as Chair) at the University of Maryland’s Robert H. Smith School of Business, where he received his B.S. in Accounting. Mr. Manoff’s extensive experience in accounting and corporate governance led to the conclusion that he should serve as a member of the Covetrus Board.
As the Independent Director of Covetrus, the total compensation of Mark Manoff at Covetrus is $307,500. There are 11 executives at Covetrus getting paid more, with Benjamin Wolin having the highest compensation of $4,065,210.
Mark Manoff is 63, he's been the Independent Director of Covetrus since 2019. There are 2 older and 24 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
Mark's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin e Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus executives and other stock owners filed with the SEC include: